Plant-Derived Natural Product-Based Nanoformulations for Healthcare Application
Nanotheranostics · 2025
DOI: 10.7150/ntno.113606 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanotheranostics, 2025. Verfasst von Saloni Kakkar und 6 weiteren Autor:innen. Beteiligte Einrichtung: CSIR-Centre for Cellular and Molecular Biology (CCMB), Uppal Road, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Biological Products, Nanoparticles, Theranostic Nanomedicine, Plants. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Plants produce numerous natural compounds developed into commercial products. These compounds offer medicinal benefits for treating diseases like diabetes, neurological disorders, malaria, and cancer. They also serve as hepatoprotective agents and immunomodulators. These natural products are secondary metabolites that plants produce for their defense and adaptation. Recently, numerous reports have highlighted the effectiveness of natural products in different diseases. However, comprehensive analysis of plant-based products currently used in the clinical setting for various human diseases is insufficient. This review provides extensive information about the application of natural plant products in both clinical and preclinical settings. It highlights their role in developing drugs for human diseases. Additionally, these plant products could serve as diagnostic tools for various diseases. Plant-derived natural products, integrated with advanced nanotechnology-based approaches, could enhance healthcare monitoring without compromising treatment efficacy. Nanotechnology techniques employing both diagnostics and therapeutics, known as nanotheranostics, utilize engineered biocompatible nanomaterials with potential prospects for healthcare management. Nanomaterials like polymeric nanoparticles and liposomes offer diagnostic value by enabling real-time imaging of disease progression and treatment response. Functionalized with contrast agents or dyes, they enhance MRI, CT, PET, and fluorescence imaging, improving diagnosis, patient stratification, and monitoring of drug delivery and efficacy. With the increasing demand for natural dietary supplements, this issue encompasses the identification of various plant-based natural products as potential nanotheranostics with promising potential for chronic disorders such as cancer, neurological pathologies, diabetes, and immunological issues. This review focuses on applications of nanotheranostics utilizing natural products in biomedical applications, outlining the current breakthroughs, supplemented with future potentialities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CSIR-Centre for Cellular and Molecular Biology (CCMB), Uppal Road, Hyderabad, Telangana, India.
- Department of Biotechnology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
- Manipal Center for Biotherapeutics Research, Manipal Academy of Higher Education, Karnataka, Manipal, 576 104, India.
- Department of Physiology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Zitieren
APA
Kakkar, S., Jha, R. K., Hattila, D., Singh, A. K., Shukla, P. K., Yadav, S. P. S., & Meena, A. S. (2025). Plant-Derived Natural Product-Based Nanoformulations for Healthcare Application. Nanotheranostics. https://doi.org/10.7150/ntno.113606
Vancouver
Kakkar S, Jha RK, Hattila D, Singh AK, Shukla PK, Yadav SPS, et al. Plant-Derived Natural Product-Based Nanoformulations for Healthcare Application. Nanotheranostics. 2025. doi:10.7150/ntno.113606
BibTeX
@article{Kakkar2025,
author = {Kakkar, Saloni and Jha, Rajan K and Hattila, Deeksha and Singh, Abhishek Kumar and Shukla, Pradeep K and Yadav, Shiv Pratap Singh and Meena, Avtar S},
title = {Plant-Derived Natural Product-Based Nanoformulations for Healthcare Application},
journal = {Nanotheranostics},
year = {2025},
doi = {10.7150/ntno.113606}
}
EUVIMED